Barbara Rehermann

Barbara Rehermann's AcademicInfluence.com Rankings

Barbara Rehermann

Biology

#11151

World Rank

#14528

Historical Rank

Immunology

#713

World Rank

#735

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Barbara Rehermann Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Barbara Rehermann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immunology of hepatitis B virus and hepatitis C virus infection (2005) (1625)
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C (2000) (932)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus (2013) (874)
The liver as an immunological organ (2006) (828)
The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response (1996) (815)
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C (2000) (790)
Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 (2002) (683)
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. (2009) (558)
The liver as an immunological organ (2004) (542)
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis (1995) (500)
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance (2017) (476)
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. (1999) (467)
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. (2007) (430)
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells (2013) (407)
Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. (1997) (359)
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. (1996) (317)
Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. (1996) (308)
Long-lasting memory T cell responses following self-limited acute hepatitis B. (1996) (305)
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients (1996) (283)
Laboratory mice born to wild mice have natural microbiota and model human immune responses (2019) (273)
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. (2010) (266)
Immune responses to HCV and other hepatitis viruses. (2014) (260)
Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair (2018) (258)
Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. (2004) (248)
Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells (2001) (244)
Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function. (2015) (227)
Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees (2003) (205)
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge (2002) (189)
Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes (2000) (184)
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. (2006) (169)
Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. (2008) (168)
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. (2011) (162)
Hepatitis C virus mutation affects proteasomal epitope processing. (2004) (160)
Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections (2015) (154)
A variant upstream of IFNL 3 ( IL 28 B ) creating a novel interferon gene IFNL 4 is associated with impaired clearance of hepatitis C virus (2012) (152)
Effects of antiviral therapy on the cellular immune response in acute hepatitis C (2004) (151)
Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. (2012) (151)
Interaction between the hepatitis C virus and the immune system. (2000) (143)
IL‐29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection (2012) (133)
Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. (2006) (130)
Cell mediated immune response to the hepatitis C virus. (2000) (130)
Hepatitis C virus infection: when silence is deception. (2003) (119)
Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. (2007) (118)
Immune responses in hepatitis B virus infection. (2003) (117)
Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. (1995) (116)
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon‐based therapy of hepatitis C patients (2012) (115)
Cell culture–produced hepatitis C virus impairs plasmacytoid dendritic cell function (2007) (114)
Natural killer cell function is intact after direct exposure to infectious hepatitis C virions (2009) (113)
Immunization with Hepatitis C Virus-Like Particles Induces Humoral and Cellular Immune Responses in Nonhuman Primates (2004) (112)
Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages (2017) (108)
Discovery of several thousand highly diverse circular DNA viruses (2019) (108)
Intrahepatic T Cells in Hepatitis B (2000) (99)
The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity (2003) (90)
Infection trains the host for microbiota-enhanced resistance to pathogens (2021) (89)
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection. (2019) (82)
Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication. (2014) (76)
Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation. (2017) (76)
The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes (2011) (75)
Acute hepatitis C: a multifaceted disease. (2005) (74)
Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus. (2012) (72)
Activation signals in human lymphocytes. Incorporation of polyunsaturated fatty acids into plasma membrane phospholipids regulates IL-2 synthesis via sustained activation of protein kinase C. (1989) (72)
Innate immune responses in hepatitis C virus‐exposed healthcare workers who do not develop acute infection (2013) (71)
Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C. (2011) (70)
Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. (2008) (69)
Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses. (2011) (65)
Natural Killer Cells in Viral Hepatitis (2015) (65)
Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model. (2001) (61)
Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity. (2004) (59)
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C (2013) (57)
Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα (2016) (57)
Immunopathology of hepatitis C (2004) (55)
Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus. (2001) (53)
Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood. (2001) (53)
Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. (2015) (53)
Cellular Immune Responses to the Hepatitis B Virus Polymerase12 (2004) (52)
Subinfectious Hepatitis C Virus Exposures Suppress T cell Responses Against Subsequent Acute Infection (2013) (51)
The Frequency of CD127+ Hepatitis C Virus (HCV)-Specific T Cells but Not the Expression of Exhaustion Markers Predicts the Outcome of Acute HCV Infection (2013) (50)
The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity. (2013) (49)
Mechanisms of alcoholic liver disease: cytokines. (2001) (48)
Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults. (2005) (48)
Immunological techniques in viral hepatitis. (2007) (47)
Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors (2018) (46)
Private aspects of heterologous immunity (2005) (44)
R2d2 Drives Selfish Sweeps in the House Mouse (2016) (44)
T cell responses in hepatitis C virus infection: historical overview and goals for future research. (2015) (44)
Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection. (2011) (42)
Keratinocyte-intrinsic MHCII expression controls microbiota-induced Th1 cell responses (2019) (41)
Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies (2002) (36)
Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct‐Acting Antiviral Therapy (2018) (35)
Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. (2008) (35)
Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection? (2014) (34)
Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study. (2013) (33)
Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions. (2014) (33)
Ribavirin improves the IFN‐γ response of natural killer cells to IFN‐based therapy of hepatitis C virus infection (2014) (33)
Hepatitis D Virus-Specific CD8+ T Cells Have a Memory-Like Phenotype Associated With Viral Immune Escape in Patients With Chronic Hepatitis D Virus Infection. (2019) (32)
B cell homeostasis in chronic hepatitis C virus–related mixed cryoglobulinemia is maintained through naïve B cell apoptosis (2012) (30)
Genetic Immunization of Wild-Type and Hepatitis C Virus Transgenic Mice Reveals a Hierarchy of Cellular Immune Response and Tolerance Induction against Hepatitis C Virus Structural Proteins (2001) (30)
Improving natural product research translation: From source to clinical trial (2019) (29)
Mucosal-Associated Invariant T Cells in Chronic Inflammatory Liver Disease (2018) (29)
HCV in 2015: Advances in hepatitis C research and treatment (2016) (28)
High levels of subgenomic HCV plasma RNA in immunosilent infections. (2007) (27)
Cellular immune response to the hepatitis C virus (1999) (27)
Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C (2005) (27)
Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype–genotype correlation study (2015) (27)
The clinical relevance of persistent recombinant immunoblot assay–indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling (2012) (26)
Proteasome activator and antigen-processing aminopeptidases are regulated by virus-induced type I interferon in the hepatitis C virus-infected liver. (2007) (26)
Trace amounts of sporadically reappearing HCV RNA can cause infection. (2014) (24)
Systemic toxoplasma infection triggers a long-term defect in the generation and function of naive T lymphocytes (2016) (22)
The Kinetics of Hepatitis C Virus-Specific CD8 T-Cell Responses in the Blood Mirror Those in the Liver in Acute Hepatitis C Virus Infection (2008) (22)
Viruses and auto‐immune hepatitis (1994) (21)
Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes. (2012) (21)
Immune responses and immunity in hepatitis C virus infection (2001) (21)
Immunopathogenesis of viral hepatitis. (1996) (20)
Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics (2017) (20)
The accelerating pace of HCV research: a summary of the 15th International Symposium on Hepatitis C Virus And Related Viruses. (2009) (18)
Hepatitis C vaccines: Inducing and challenging memory T cells (2006) (18)
6 Immunopathogenesis of viral hepatitis (1996) (17)
Liver-resident bystander CD8+ T cells contribute to liver disease pathogenesis in chronic hepatitis D virus infection (2021) (16)
Taking the brake off T cells in chronic viral infection (2006) (16)
R 2 d 2 Drives Selfish Sweeps in the House Mouse (2016) (15)
A rare case of bloody diarrhea: thrombosis of the V. mesenterica inferior following laparoscopic cholecystectomy. (1998) (14)
Mature peritoneal macrophages take an avascular route into the injured liver and promote tissue repair (2017) (14)
More rare birds, and the occasional swan. (2009) (14)
Neonatal exposure to a wild-derived microbiome protects mice against diet-induced obesity (2021) (13)
Clearance of pegylated interferon by Kupffer cells limits NK cell activation and therapy response of patients with HBV infection (2021) (13)
Hepatitis C Virus Infection T Cells in Chronic + Virus-Specific CD8 Impaired Effector Function of Hepatitis C (2002) (12)
Intrahepatic T Cells in Hepatitis B: Viral Control versus Liver Cell Injury (2000) (11)
Chronic hepatitis B and hepatocarcinogenesis: Does prevention of “collateral damage” bring the cure? (2003) (10)
Tissue-resident T cells in hepatitis B: A new target for cure? (2017) (10)
Identification of novel chimpanzee MHC class I and II alleles using an improved sequence-based typing strategy. (2006) (10)
Serological pattern of hepatitis C virus recurrence after liver transplantation. (1996) (9)
Interleukin-6 in liver diseases. (1992) (8)
Acute hepatitis C. (2009) (8)
The role of genetics in hepatic fibrosis among hepatitis C virus patients (2017) (7)
Virus-Induced Interferon Regulates the Urea Cycle. (2019) (6)
Impaired effector function of HCV-specific CD8+ T cells in chronic hepatitis C virus infection (2001) (6)
Immunologic aspects of acute and chronic hepatitis B and C (1996) (5)
Ethnicity and hepatitis C virus infection. (2004) (5)
Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge. (2010) (5)
Hepatitis C virus and the threshold of natural killer cell inhibition (2005) (5)
Wild mouse gut microbiome protects laboratory mice against lethal influenza virus infection and colorectal cancer (2017) (4)
Inflammation drives an altered phenotype of mucosal-associated invariant T cells in chronic hepatitis D virus infection. (2019) (4)
Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C (2022) (4)
Natural versus Laboratory World: Incorporating Wild-Derived Microbiota into Preclinical Rodent Models (2021) (4)
Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
111 HCV-specific cellular immune responses in subjects who are antiHCV-negative, HCV RNA-negative despite longterm (>15 years) injection drug use (2003) (3)
Determination of hepatitis B virus-specific CD8+ T-cell activity in the liver. (2004) (3)
Chronic HCV infection and the clonality of intrahepatic T cells. (2003) (3)
Peptide-dependent HLA-KIR-mediated regulation of NK cell function. (2016) (3)
THE IMMUNOLOGY OF CHRONIC HEPATITIS B (1998) (3)
Hepatic NK, NKT and T cells (2007) (3)
8 Immunopathogenesis of hepatitis C (2000) (3)
Gastroenterologic manifestations of mastocytosis. (1994) (2)
Identification of four novel MHC-C alleles in chimpanzees. (2007) (2)
182 : Identification and characterization of interferon-λ4 (IFN-λ4), a novel class-2 cytokine which impairs clearance of hepatitis C virus (2013) (2)
Determination of HCV-specific T-cell activity. (2009) (2)
Hepatitis C Virus Attenuates Interferon-Induced MHC Class I Expression and Decreases CD 8 + T-Cell Effector Functions (2015) (2)
Ribavirin Pretreatment Improves the IFN-γ Response of Natural Killer Cells to IFN-based Therapy of Hepatitis C Virus Infection (2014) (1)
Title A variant upstream of IFNL 3 ( IL 28 B ) creating a novel interferon gene IFNL 4 is associated with impaired clearance of hepatitis C virus (2013) (1)
Cells With Antiviral Functions (2016) (1)
Analysis of HCV-specific T cells by flow cytometry. (2009) (1)
P156 RIBAVIRIN PRETREATMENT IMPROVES THE IFN-γ RESPONSE OF NATURAL KILLER CELLS TO IFN-BASED THERAPY OF HEPATITIS C VIRUS INFECTION (2014) (1)
Faculty Opinions recommendation of Deliberate removal of T cell help improves virus-neutralizing antibody production. (2004) (1)
Spontaneous Clearance of Drug‐Resistant Chronic Hepatitis C Virus Infection (2021) (1)
Viral escape from the HLA-A2 restricted cytotoxic T lymphocyte response is not common during chronic hepatitis C virus infection (1995) (1)
Cellular Immune Responses to the Hepatitis B Virus Polymerase 1 , 2 (2004) (1)
A rare case of recurrent intrahepatic cholestasis of pregnancy with prolonged postpartum hepatic inflammation despite normalization of bile acid levels (2022) (1)
Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles. (2008) (1)
Hepatosplenomegaly as the only gastrointestinal sign of systemic mastocytosis (1994) (1)
GOR-antibodies in patients with chronic liver disease and hepatocellular carcinoma. (1994) (1)
Faculty Opinions recommendation of Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. (2005) (1)
Reply: B‐cell frequency in HCV‐related mixed cryoglobulinemia (2013) (1)
65 Induction of HCV-specific immune responses by hepatitis C virus-like particles in non-human primates: implications for prevention and therapy of hepatitis C (2003) (1)
Trafficking of HCV-specific CD8 T cells to the liver in the early phase of acute hepatitis C (2004) (1)
Infection Trains the Microbiota for Enhanced Resistance to Pathogens (2020) (0)
The cytotoxic T cell response after interferon-induced recovery from hepatitis C (1997) (0)
Effect of liver-specific IFN-g expression in chronic hepatitis C virus infection (2003) (0)
Delayed induction not impaired recruitment of HCV-specific CD8 T cells is resonsible for the late onset of acute hepatitis (2009) (0)
Double-stranded RNA-induced type I IFN induces immunoproteasomes during viral infection (2006) (0)
Faculty Opinions recommendation of A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. (2011) (0)
the Outcome of Acute HCV Infection Expression of Exhaustion Markers Predicts (HCV)-Specific T Cells but Not the Hepatitis C Virus + The Frequency of CD127 (2014) (0)
State-of-the-Art Lecture: The liver as an immune organ (2009) (0)
Antigen-specific natural killer cell cytokine production in chronic hepatitis C infection (P6062) (2013) (0)
Development of genetically engineered TCR-transduced T cells for immunotherapy of chronic hepatitis B and C virus infections (P4222) (2013) (0)
Faculty Opinions recommendation of A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. (2005) (0)
the Outcome of Acute HCV Infection Expression of Exhaustion Markers Predicts (HCV)-Specific T Cells but Not the The Frequency of CD127+ Hepatitis C Virus (2013) (0)
Immune cell phenotype and function in different compartments of the gut-liver-axis in chronic liver disease (2017) (0)
Monocytes sense hepatitis C virus-replicating cells and induce natural killer cell antiviral activity in an IL-18-mediated manner (INC8P.437) (2014) (0)
Abstract 3751: Expression analysis of the IL28A, IL28B, IL29 and IL28L genes in primary human peripheral blood mononuclear cells and hepatocytes: Effects of activation mode, time-course and genotypes (2011) (0)
A selfish genetic element drives recurring selective sweeps in the house mouse (2015) (0)
Transcriptome analysis reveals distinct immune response profiles in HBeAg+ and HBeAg− HBV infection and in HBV/HDV co-infection (2017) (0)
Faculty Opinions recommendation of Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. (2004) (0)
Reply (2004) (0)
Identification of a new Patr-B*01 variant, Patr-B*0102, by sequence-based typing in a chimpanzee (Pan troglodytes). (2010) (0)
Proteasomal antigen-processing is regulated by cytokines of the innate immune response in acute HCV infection (2005) (0)
Identification of new major histocompatibility complex-A, -B, -C alleles in chimpanzees (Pan troglodytes). (2008) (0)
Faculty Opinions recommendation of An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. (2004) (0)
THE PERCENTAGE OF HEPATITIS C VIRUS-SPECIFIC CD127+MEMORY T CELLS IN THE ACUTE PHASE T CELL RESPONSE PREDICTS THE OUTCOME OF HCV INFECTION (2011) (0)
[Epigastric colic caused by biliary escape of a hydatid entity from an echinococcus cyst]. (1992) (0)
O.069 Innate and adaptive immune responses to HCV (2006) (0)
Faculty Opinions recommendation of Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. (2012) (0)
Symposium 1: Hepatic Fibrosis, Basic to Clinical [1] : Hepatitis Virus Induced Hepatic Inflammation and Fibrosis (2014) (0)
ImmuneResponses toHCVandOtherHepatitisViruses (2015) (0)
Visualisation of hepatitis C virus-specific cytotoxic T cells using peptide-MHC tetramers: Variations in the viral epitope and relationship with the viral load (2000) (0)
KIR/HLA Compound Genotypes Determine Early Antiviral Response of Natural Killer Cells (35.17) (2007) (0)
Natural History , Treatment , and Prevention of Hepatitis C Moderator : (2000) (0)
64 Effect of early antiviral therapy on the cellular immune response in acute hepatitis C (2003) (0)
CD8 T cells are recruited to the liver in acute hepatitis C by HCV RNA-induced CXCR3- and CCR5-ligands (2006) (0)
[Rare initial manifestation and differential diagnosis of primary sclerosing cholangitis]. (1997) (0)
State-of-the-Art Lecture: Immune responses and viral escape mechanisms in hepatitis C virus infection (2009) (0)
Monocytes Affect Natural Killer cell Antiviral IFN-γ Production in HCV Infection via Inflammasome-mediated IL-18 Secretion (2014) (0)
Activation of intrahepatic mucosal associated invariant T cells resolves with antiviral therapy for hepatitis C (2017) (0)
Activation of plasma membrane phospholipid metabolism is a necessary early signal for interleukin-2 production in human lymphocytes (1988) (0)
Immunity Review ImmuneResponses toHCVandOtherHepatitisViruses (2014) (0)
Insights From Antiviral Therapy into Immune Responses to HBV and HCV Infection (2019) (0)
Hepatitis Virus Induced Hepatic Inflammation and Fibrosis (2014) (0)
34 Crosspriming of hepatitis C virus specific CD8+ T cells in mice by immunization with dentritic cells transfected with self-replicating RNA (2003) (0)
Hepatitis C Virus Attenuates Interferon-induced MHC Class I Expression via PKR Activation to Circumvent CD8 + T-cell Responses (2014) (0)
625 Peripheral blood and intrahepatic CD4/CD8 double positive cells in hepatitis C virus infection (2003) (0)
HCV Activates Protein Kinase R and Attenuates Interferon-Induced MHC Class I Expression to Circumvent CD8+ T-Cell Responses (2015) (0)
1149 Cellular immune responses to the hepatitis B virus polymerase decrease during longterm antiviral therapy (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Barbara Rehermann?

Barbara Rehermann is affiliated with the following schools:

New York University

Barbara Rehermann's Academic­Influence.com Rankings

Why Is Barbara Rehermann Influential?

Barbara Rehermann's Published Works

Published Works

What Schools Are Affiliated With Barbara Rehermann?

Barbara Rehermann's AcademicInfluence.com Rankings